DVAX has been granted a new patent
Nov 27, 2024, 11:32 PM
0.93%
What does DVAX do
Dynavax Technologies is a biopharmaceutical company based in Emeryville, California, specializing in vaccines and immuno-oncology therapeutics, including the HEPLISAV-B hepatitis B vaccine. The company is developing additional vaccines, including candidates for shingles and Tdap.
DVAX filed a patent for "alkyl chain modified imidazoquinoline tlr7/8 agonist compounds and uses thereof" on Mon, April 8, 2024. The patent was officially published on Thu, November 7, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.